6/13/2013

California's decision to stop transitioning its Medi-Cal pharmacy reimbursement model from average wholesale price to average acquisition cost may signal support for CMS efforts to set national benchmarks, writes industry expert Adam Fein.

Full Story:
Drug Channels

Related Summaries